This study provides a systematic pipeline to delineate cancer progression-associated cell subpopulations, uncovers metabolic<sup>high</sup><i>UBE2C+</i> cancer cells as progression-associated tumor cell population, and nominates critical regulators and compounds as therapeutic targets. The gene discussed is UBE2C; the disease is neoplasm.